Sofía Luján Basil

Analytical Project Lead at Siegfried Holding

Sofía Luján Basil has extensive experience in the analytical project lead and quality control fields. Sofía Luján currently holds the position of Analytical Project Lead at Siegfried Holding AG since January 2023. Prior to that, they worked as the Coordinator of Quality Control at Fatro Von Franken from July 2020 to December 2022, where they were responsible for staff training and document correction. Sofía Luján also worked as a Senior Analytical Development Analyst at Laboratorios Richmond SACIF from September 2012 to July 2020, conducting analysis of raw materials, stability testing, and validation of analytical methods. Additionally, Sofía worked as a Laboratory Analyst in the Chemistry Department at Microquim S.A. from March 2012 to September 2012, where they performed physical and chemical property control tests on agricultural chemicals.

Sofía Luján Basil has a diverse education history. Sofía Luján completed their degree in Pharmacy at Universidad Kennedy from 2015 to 2019. Prior to that, they pursued their undergraduate studies in Pharmacy at Facultad de Farmacia y Bioquímica-Universidad de Buenos Aires-UBA, from 2009 to 2015. Sofía began their educational journey by attending Escuela Técnica Nº27 DE 18 "Hipólito Yrigoyen" from 2002 to 2008, where they earned a degree in Técnica Química.

Location

Barcelona, Spain

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Siegfried Holding

1 followers

Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.


Industries

Employees

1,001-5,000

Links